Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Crossing Over

April 6th, 2007

Crossing Over

Abstract:
Microarrays have also made the transition from the drug discovery market to point-of-care application. Researchers typically apply microarrays to genotyping, mutation screening, gene expression, and protein-interaction studies.

Typically microarrays provide ever more information per experiment. In the drug discovery arena, researchers use microarrays to perform large-scale studies in larger populations than ever before, providing a more comprehensive view of the human genetic variations that cause common diseases.

Source:
dddmag.com

Bookmark:

Related News Press

Nanomedicine

How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013

MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013

Nanoparticle Delivers Large Protein Complex to Cancer Cell Nucleus May 20th, 2013

Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals

International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013

Rice unveils method for tailoring optical processors: Arranging nanoparticles in geometric patterns allows for control of light with light May 21st, 2013

Nanoparticle Harnesses Powerful Radiation Therapy for Cancer May 20th, 2013

Microneedle-Delivered Nanoparticles Boost Antitumor Vaccines May 20th, 2013